Arrowgrass Capital Partners (US)
ORGO icon

Arrowgrass Capital Partners (US)’s Organogenesis Holdings ORGO Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,793,000
Closed -$17.8M – 386
2017
Q4 		$17.8M Buy
1,793,000
+293,000
+20% +$2.91M 0.17% 144
2017
Q3 		$15M Buy
+1,500,000
New +$14.9M 0.11% 223

Other funds holding ORGO

Glazer Capital LLC
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
ArrowMark Colorado Holdings
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Angelo Gordon & Co
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
Fir Tree Capital Management
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
Polar Asset Management Partners
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Governors Lane
Governors Lane New York $1.2B AUM 26.21% 1-Year Est. Return
Moore Capital Management
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
Davidson Kempner Capital Management
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s ORGO Position: Q1 2018 in Review

Arrowgrass Capital Partners (US) sold out of Organogenesis Holdings (ORGO) in Q1 2018, closing a stake of 1,793,000 shares — an estimated $17.8M sold.

Arrowgrass Capital Partners (US) first reported a position in ORGO in Q3 2017 and held it in 2 quarters. The position peaked at $17.8M in Q4 2017. 31 funds tracked by Wall St. Rank hold ORGO as of Q1 2018.

  • Arrowgrass Capital Partners (US) reported no remaining Organogenesis Holdings position as of Q1 2018 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 1,793,000 Organogenesis Holdings shares in Q1 2018, an estimated $17.8M.
  • Arrowgrass Capital Partners (US) first reported a position in Organogenesis Holdings in Q3 2017 and held it in 2 quarters.
  • Arrowgrass Capital Partners (US)'s Organogenesis Holdings position peaked at $17.8M in Q4 2017.
  • 31 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2018.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q1 2018, filed 15 May 2018.